NCT07324629 2026-01-09Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic CarcinomaSichuan Kelun Pharmaceutical Research Institute Co., Ltd.Phase 2 Not yet recruiting30 enrolled